SYRE - Spyre Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$97.64
DETAILS
HIGH:
$135.00
LOW:
$49.00
MEDIAN:
$100.00
CONSENSUS:
$97.64
UPSIDE:
3.74%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 0 | $0 | -- | -662,351 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-01 | Burrows Scott L | officer: Chief Financial Officer | SELL | 1,725 | $88.37 | $152K |
| 2026-07-01 | Burrows Scott L | officer: Chief Financial Officer | SELL | 5,775 | $87.55 | $506K |
| 2026-07-01 | Sloan Sheldon | officer: Chief Medical Officer | SELL | 6,500 | $87.52 | $569K |
| 2026-07-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 10,176 | $87.44 | $890K |
| 2026-07-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 4,234 | $88.12 | $373K |
| 2026-07-01 | Burrows Scott L | officer: Chief Financial Officer | M-Exempt | 7,500 | $14.50 | $109K |
| 2026-07-01 | Sloan Sheldon | officer: Chief Medical Officer | M-Exempt | 8,334 | $27.46 | $229K |
| 2026-07-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 590 | $88.91 | $52K |
| 2026-07-01 | Sloan Sheldon | officer: Chief Medical Officer | SELL | 1,834 | $88.34 | $162K |
| 2026-06-25 | Burrows Scott L | officer: Chief Financial Officer | M-Exempt | 15,000 | $14.50 | $218K |
| 2026-06-25 | Burrows Scott L | officer: Chief Financial Officer | SELL | 5,000 | $87.12 | $436K |
| 2026-06-25 | Burrows Scott L | officer: Chief Financial Officer | SELL | 10,000 | $87.14 | $871K |
| 2026-06-23 | Fairmount Funds Management LLC | director | C-Conversion | 666,680 | -- | -- |
| 2026-06-23 | Fairmount Funds Management LLC | director | SELL | 4,684,781 | $85.31 | $399.7M |
| 2026-06-23 | Fairmount Funds Management LLC | director | C-Conversion | 16,667 | -- | -- |
| 2026-06-22 | HENDERSON MICHAEL THOMAS | director | SELL | 20,000 | $100.00 | $2.0M |
| 2026-06-03 | Sloan Sheldon | officer: Chief Medical Officer | M-Exempt | 8,333 | $27.46 | $229K |
| 2026-06-03 | Sloan Sheldon | officer: Chief Medical Officer | SELL | 8,333 | $75.00 | $625K |
| 2026-06-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 3,294 | $71.38 | $235K |
| 2026-06-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 3,557 | $69.40 | $247K |
| 2026-06-01 | Burrows Scott L | officer: Chief Financial Officer | SELL | 1,801 | $69.75 | $126K |
| 2026-06-01 | Burrows Scott L | officer: Chief Financial Officer | M-Exempt | 7,500 | $14.50 | $109K |
| 2026-06-01 | Turtle Cameron | director, officer: Chief Executive Officer | SELL | 8,149 | $70.50 | $575K |
| 2026-06-01 | Burrows Scott L | officer: Chief Financial Officer | SELL | 3,100 | $72.06 | $223K |
| 2026-06-01 | Burrows Scott L | officer: Chief Financial Officer | SELL | 2,599 | $70.77 | $184K |